Recruiting Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia NCT07394153 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more Locations Hospital del Mar Barcelona — Barcelona, Spain Hospital Universitario Vall d´Hebron — Barcelona, Spain Hospital Clinic de Barcelona — Barcelona, Spain Hospital Universitario de Jerez — Jerez de la Frontera, Cádiz, Spain View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined NCT06414681 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more Locations The University of Kansas Cancer Center — Fairway, Kansas, United States View Trial Details
Recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225 Conditions Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more Locations MPN Research Foundation — Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Completed Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative NCT05153343 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more Locations West China Hospital Sichuan University — Chengdu, Sichuan, China View Trial Details
